SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, each of
the registrants has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
|
BARCLAYS
PLC
|
|
(Registrant)
|
Date:
June 01, 2017
|
By: /s/
Marie Smith
--------------------------------
|
|
Marie
Smith
|
|
Assistant
Secretary
|
|
BARCLAYS
BANK PLC
|
|
(Registrant)
|
Date:
June 01, 2017
|
By: /s/
Marie Smith
--------------------------------
|
|
Marie
Smith
|
|
Assistant
Secretary
|
Exhibit
No. 1
2 May
2017
Barclays PLC - Total Voting Rights
In
accordance with the Financial Conduct Authority's (FCA) Disclosure
Guidance and Transparency Rule 5.6.1R, Barclays PLC notifies the
market that as of 30 April 2017, Barclays PLC's issued share
capital consists of 17,030,191,601 Ordinary shares with voting
rights.
There
are no ordinary shares held in Treasury.
The
above figure (17,030,191,601)may be used by shareholders (and
others with notification obligations) as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change to their interest in,
Barclays PLC under the FCA's Disclosure Guidance and Transparency
Rules.
- Ends -
For
further information, please contact:
Investor
Relations
|
Media
Relations
|
Kathryn
McLeland
|
Tom
Hoskin
|
+44 (0)
20 7116 4943
|
+44
(0) 20 7116 4755
|
LEI
Code: 213800LBQA1Y9L22JB70
Exhibit
No. 2
3 May
2017
NOTIFICATION
OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
a)
|
Name
|
Sir Ian
Cheshire
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Non-executive
Director
|
b)
|
Initial
notification /Amendment
|
Initial
notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Barclays
PLC
|
b)
|
LEI
|
213800LBQA1Y9L22JB70
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description
of the financial instrument, type of instrument
Identification
code
|
Ordinary
shares in Barclays PLC with a nominal value of 25p each
("Shares")
GB0031348658
|
b)
|
Nature
of the transaction
|
Purchase
of Shares
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s):
Number of Shares purchased
|
£2.10
|
50,000
|
d)
|
Aggregated
information
-
Aggregated volume
-
Price
|
N/A
|
e)
|
Date of
the transaction
|
2017-05-02
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
a)
|
Name
|
Ashok
Vaswani
|
2
|
Reason for the notification
|
a)
|
Position/status
|
CEO,
Barclays UK
|
b)
|
Initial
notification /Amendment
|
Initial
notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Barclays
PLC
|
b)
|
LEI
|
213800LBQA1Y9L22JB70
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description
of the financial instrument, type of instrument
Identification
code
|
Ordinary
shares in Barclays PLC with a nominal value of 25p each
("Shares")
GB0031348658
|
b)
|
Nature
of the transaction
|
Barclays
Wealth Nominees Limited sold Shares for the individual set out
above
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s):
Number of Shares sold
|
£2.12
|
650,230
|
d)
|
Aggregated
information
-
Aggregated volume
-
Price
|
N/A
|
e)
|
Date of
the transaction
|
2017-04-28
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
For
further information please contact:
Investor
Relations
|
Media
Relations
|
Kathryn
McLeland
|
Tom
Hoskin
|
+44
(0)20 7116 4943
|
+44
(0)20 7116 4755
|
Exhibit
No. 3
Publication of Base Prospectus Supplement
The
following base prospectus supplement has been approved by the UK
Listing Authority and is available for viewing:
Base
Prospectus Supplement No. 1 dated 4 May 2017 to the Base Prospectus
dated 28 February 2017 for the Barclays PLC and Barclays Bank PLC
£60,000,000,000 Debt Issuance Programme
To view
the full document, please paste the following URL into the address
bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/3108E_-2017-5-5.pdf
A copy
of the above document has been submitted to the National Storage
Mechanism and will shortly be available for inspection at:
http://www.morningstar.co.uk/uk/NSM
For
further information, please contact:
Barclays
Treasury
1
Churchill Place
Canary
Wharf
London
E14 5HP
DISCLAIMER
- INTENDED ADDRESSEES
IMPORTANT:
You must read the following before continuing:
The following applies to the Base Prospectus Supplement available
by clicking on the link above, and you are therefore advised to
read this carefully before reading, accessing or making any other
use of the Base Prospectus Supplement. In accessing the Base
Prospectus Supplement, you agree to be bound by the following terms
and conditions, including any modifications to them, any time you
receive any information from us as a result of such
access.
THE
BASE PROSPECTUS SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED
OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY
MANNER WHATSOEVER. THE BASE PROSPECTUS SUPPLEMENT MAY ONLY BE
DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S.
PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "
SECURITIES ACT
") OR WITHIN THE UNITED
STATES TO QIBs (AS DEFINED BELOW) IN ACCORDANCE WITH RULE 144A
UNDER THE SECURITIES ACT ("
RULE
144A
"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE
BASE PROSPECTUS SUPPLEMENT IN WHOLE OR IN PART IS PROHIBITED.
FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE
SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER
JURISDICTIONS.
NOTHING
IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES
FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. ANY
NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE PROSPECTUS
RELATING TO THE BARCLAYS PLC AND BARCLAYS BANK PLC
£60,000,000,000 DEBT ISSUANCE PROGRAMME (THE "
BASE PROSPECTUS
") AND THE BASE
PROSPECTUS SUPPLEMENT HAVE NOT BEEN, AND WILL NOT BE, REGISTERED
UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE
UNITED STATES OR OTHER JURISDICTION. ANY NOTES ISSUED OR TO BE
ISSUED PURSUANT TO THE BASE PROSPECTUS AND THE BASE PROSPECTUS
SUPPLEMENT MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED EXCEPT (1) IN ACCORDANCE WITH RULE 144A UNDER THE
SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED
INSTITUTIONAL BUYERS (EACH A "
QIB
") WITHIN THE MEANING OF RULE 144A OR
(2) IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S.
PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S
UNDER THE SECURITIES ACT.
Please
note that the information contained in the Base Prospectus
Supplement may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Base
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Base Prospectus is not addressed. Prior
to relying on the information contained in the Base Prospectus and
the Base Prospectus Supplement you must ascertain from the Base
Prospectus whether or not you are part of the intended addressees
of the information contained therein.
Confirmation of your Representation:
In order to be eligible
to view the Base Prospectus Supplement or make an investment
decision with respect to any Notes issued or to be issued pursuant
to the Base Prospectus and the Base Prospectus Supplement, you must
be (i) a person other than a U.S. person (within the meaning of
Regulation S under the Securities Act); or (ii) a QIB that is
acquiring the securities for its own account or for the account of
another QIB. By accessing the Base Prospectus Supplement, you shall
be deemed to have represented that you and any customers you
represent are not a U.S. person (as defined in Regulation S to the
Securities Act) or that you are a QIB, and that you consent to
delivery of the Base Prospectus Supplement and any supplements
thereto via electronic publication.
You are
reminded that the Base Prospectus Supplement has been made
available to you on the basis that you are a person into whose
possession the Base Prospectus Supplement may be lawfully delivered
in accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Base Prospectus Supplement to any other person.
The
Base Prospectus Supplement does not constitute, and may not be used
in connection with, an offer or solicitation in any place where
offers or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuers in such jurisdiction. Under no circumstances
shall the Base Prospectus Supplement constitute an offer to sell,
or the solicitation of an offer to buy, nor shall there be any sale
of any Notes issued or to be issued pursuant to the Base Prospectus
and the Base Prospectus Supplement, in any jurisdiction in which
such offer, solicitation or sale would be unlawful.
The
Base Prospectus Supplement has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuers, their
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Base Prospectus Supplement made
available to you in electronic format and the hard copy version
available to you on request from the issuers.
LEI
Code: 213800LBQA1Y9L22JB70
Exhibit
No. 4
Publication of Base Prospectus Supplement
The
following base prospectus supplement has been approved by the UK
Listing Authority and is available for viewing:
Base
Prospectus Supplement No. 1 dated 10 May 2017 to the Base
Prospectus dated 27 September 2016 for the Barclays Bank PLC
€35,000,000,000 Global Covered Bond Programme
To view
the full document, please paste the following URL into the address
bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/8701E_-2017-5-11.pdf
A copy
of the above document has been submitted to the National Storage
Mechanism and will shortly be available for inspection at:
http://www.morningstar.co.uk/uk/NSM
For
further information, please contact:
Barclays
Treasury
1
Churchill Place
Canary
Wharf
London
E14 5HP
DISCLAIMER
- INTENDED ADDRESSEES
IMPORTANT:
You must read the
following before continuing: The following applies to the Base
Prospectus Supplement available by clicking on the link above, and
you are therefore advised to read this carefully before reading,
accessing or making any other use of the Base Prospectus
Supplement. In accessing the Base Prospectus Supplement, you agree
to be bound by the following terms and conditions, including any
modifications to them, any time you receive any information from us
as a result of such access.
THE
BASE PROSPECTUS SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED
OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY
MANNER WHATSOEVER. THE BASE PROSPECTUS SUPPLEMENT MAY ONLY BE
DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S.
PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE
U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "
SECURITIES ACT
") OR WITHIN THE UNITED
STATES TO QIBs (AS DEFINED BELOW) IN ACCORDANCE WITH RULE 144A
UNDER THE SECURITIES ACT ("
RULE
144A
"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE
BASE PROSPECTUS SUPPLEMENT IN WHOLE OR IN PART IS PROHIBITED.
FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE
SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER
JURISDICTIONS.
NOTHING
IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES
FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. ANY
NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE PROSPECTUS
RELATING TO THE BARCLAYS BANK PLC €35,000,000,000 GLOBAL
COVERED BOND PROGRAMME (THE "
BASE
PROSPECTUS
") AND THE BASE PROSPECTUS SUPPLEMENT HAVE NOT
BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE
SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER
JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE
PROSPECTUS AND THE BASE PROSPECTUS SUPPLEMENT MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) IN ACCORDANCE
WITH RULE 144A UNDER THE SECURITIES ACT TO PERSONS REASONABLY
BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS (EACH A "
QIB
") WITHIN THE MEANING OF RULE 144A OR
(2) IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S.
PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S
UNDER THE SECURITIES ACT.
Please
note that the information contained in the Base Prospectus
Supplement may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Base
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Base Prospectus is not addressed. Prior
to relying on the information contained in the Base Prospectus and
the Base Prospectus Supplement you must ascertain from the Base
Prospectus whether or not you are part of the intended addressees
of the information contained therein.
Confirmation of your Representation:
In order to be eligible
to view the Base Prospectus Supplement or make an investment
decision with respect to any Notes issued or to be issued pursuant
to the Base Prospectus and the Base Prospectus Supplement, you must
be (i) a person other than a U.S. person (within the meaning of
Regulation S under the Securities Act); or (ii) a QIB that is
acquiring the securities for its own account or for the account of
another QIB. By accessing the Base Prospectus Supplement, you shall
be deemed to have represented that you and any customers you
represent are not a U.S. person (as defined in Regulation S to the
Securities Act) or that you are a QIB, and that you consent to
delivery of the Base Prospectus Supplement and any supplements
thereto via electronic publication.
You are
reminded that the Base Prospectus Supplement has been made
available to you on the basis that you are a person into whose
possession the Base Prospectus Supplement may be lawfully delivered
in accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Base Prospectus Supplement to any other person.
The
Base Prospectus Supplement does not constitute, and may not be used
in connection with, an offer or solicitation in any place where
offers or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuers in such jurisdiction. Under no circumstances
shall the Base Prospectus Supplement constitute an offer to sell,
or the solicitation of an offer to buy, nor shall there be any sale
of any Notes issued or to be issued pursuant to the Base Prospectus
and the Base Prospectus Supplement, in any jurisdiction in which
such offer, solicitation or sale would be unlawful.
The
Base Prospectus Supplement has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuers, their
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Base Prospectus Supplement made
available to you in electronic format and the hard copy version
available to you on request from the issuers.
LEI
Code:
G5GSEF7VJP5I7OUK5573
Exhibit
No. 5
Publication of Final Terms
The
following final terms (the "
Final
Terms
") are available for viewing:
Final Terms in relation to Series 2017-1 £1,000,000,000
Floating Rate Covered Bonds due May 2020 issued under the €35
billion Global Covered Bond Programme of Barclays Bank
PLC
Please
read the disclaimer below "Disclaimer - Intended Addressees" before
attempting to access this service, as your right to do so is
conditional upon complying with the requirements set out
below.
To view
the full document, please click on or paste the following URL into
the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/8250F_-2017-5-22.pdf
A copy
of the
above
Final Terms has been submitted to the National Storage Mechanism
and will shortly be available for inspection at:
http://www.morningstar.co.uk/uk/NSM
The
Final Terms can also be viewed via:
http://www.barclays.com/prospectuses-and-documentation/secured-funding-documentation/covered-bonds.html
For further information, please contact:
Barclays
Treasury
1
Churchill Place
Canary
Wharf
London
E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT:
You must read the
following before continuing: The following applies to the Final
Terms available by clicking on the link above, and you are
therefore advised to read this carefully before reading, accessing
or making any other use of the Final Terms. In accessing the Final
Terms, you agree to be bound by the following terms and conditions,
including any modifications to them, any time you receive any
information from us as a result of such access.
The
Final Terms referred to above must be read in conjunction with the
base prospectus dated 27 September 2016, as supplemented on 10 May
2017, relating to the above programme (the "
Prospectus
"), which together constitute
a base prospectus for the purposes of the Prospectus Directive
(Directive 2003/71/EC, as amended).
THE
FINAL TERMS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS
PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER.
THE FINAL TERMS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES
TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE
ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED
(THE "
SECURITIES ACT
") OR
WITHIN THE UNITED STATES TO QIBs (AS DEFINED BELOW) IN ACCORDANCE
WITH RULE 144A UNDER THE SECURITIES ACT ("
RULE 144A
"). ANY FORWARDING,
DISTRIBUTION OR REPRODUCTION OF THE FINAL TERMS IN WHOLE OR IN PART
IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A
VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER
JURISDICTIONS.
NOTHING
IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES
FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. ANY
COVERED BONDS ISSUED OR TO BE ISSUED PURSUANT TO THE FINAL TERMS
HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT
OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER
JURISDICTION. ANY COVERED BONDS ISSUED OR TO BE ISSUED PURSUANT TO
THE FINAL TERMS MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED EXCEPT (1) IN ACCORDANCE WITH RULE 144A UNDER THE
SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED
INSTITUTIONAL BUYERS (EACH A "
QIB
") WITHIN THE MEANING OF RULE 144A OR
(2) IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S.
PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S
UNDER THE SECURITIES ACT.
Please
note that the information contained in the Final Terms and the
Prospectus referred to above may be addressed to and/or targeted at
persons who are residents of particular countries (specified in the
Final Terms and/or the Prospectus) only and is not intended for use
and should not be relied upon by any person outside these countries
and/or to whom the offer contained in the Final Terms and/or the
Prospectus is not addressed. Prior to relying on the information
contained in the Final Terms and/or the Prospectus you must
ascertain from the Final Terms and the Prospectus whether or not
you are part of the intended addressees of the information
contained therein.
Confirmation of your Representation:
In order to be eligible
to view the Final Terms or make an investment decision with respect
to any Covered Bonds issued or to be issued pursuant to the Final
Terms, you must be (i) a person other than a U.S. person (within
the meaning of Regulation S under the Securities Act); or (ii) a
QIB that is acquiring the securities for its own account or for the
account of another QIB. By accessing the Final Terms, you shall be
deemed to have represented that you and any customers you represent
are not a U.S. person (as defined in Regulation S to the Securities
Act) or that you are a QIB, and that you consent to delivery of the
Final Terms and any via electronic publication.
You are
reminded that the Final Terms has been made available to you on the
basis that you are a person into whose possession the Final Terms
may be lawfully delivered in accordance with the laws of the
jurisdiction in which you are located and you may not, nor are you
authorised to, deliver the Final Terms to any other
person.
The
Final Terms does not constitute, and may not be used in connection
with, an offer or solicitation in any place where offers or
solicitations are not permitted by law. If a jurisdiction requires
that the offering be made by a licensed broker or dealer and the
underwriters or any affiliate of the underwriters is a licensed
broker or dealer in that jurisdiction, the offering shall be deemed
to be made by the underwriters or such affiliate on behalf of the
issuer in such jurisdiction. Under no circumstances shall the Final
Terms constitute an offer to sell, or the solicitation of an offer
to buy, nor shall there be any sale of any Covered Bonds issued or
to be issued pursuant to the Final Terms, in any jurisdiction in
which such offer, solicitation or sale would be
unlawful.
The
Final Terms has been made available to you in an electronic form.
You are reminded that documents transmitted via this medium may be
altered or changed during the process of electronic transmission
and consequently none of the issuer, its advisers nor any person
who controls any of them nor any director, officer, employee nor
agent of it or affiliate of any such person accepts any liability
or responsibility whatsoever in respect of any difference between
the Final Terms made available to you in electronic format and the
hard copy version available to you on request from the
issuer.